MeiraGTx Holdings plc: Chief sci ofcr, ophthalmology Stuart Naylor sold 27,659 shares

What happened Stuart Naylor, chief sci ofcr, ophthalmology, reported sale of 27,659 shares in an open market or private sale at a weighted average price of $10.64 per share for total proceeds of $294,292 on Oct 6, 2026.

Key details

• Transaction date and price: Oct 6, 2026; weighted average price $10.64; individual sale prices ranged from $10.53 to $10.88.
• Shares owned after the transaction: the filing does not state shares owned following the sale.
• Footnotes: sales were effected under a Rule 10b5-1 trading plan adopted Dec 9, 2025; the $10.64 is a weighted average and the reporting person can provide the number of shares sold at each separate price upon request.
• Filing timeliness: Form 4 was filed on Oct 6, 2026 (same day as the reported transaction).

Why it may matter The filing reports a market sale executed under a Rule 10b5-1 trading plan. A filing does not show why the insider traded or why the company acted.